Physician profile
Scott Vizzi
NPI 1396006482
$30,525.02
in general payments reported to CMS, 2019-2025
32 companies · $4,867 in 2025
The $4,867 reported for 2025 was more than what 81% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,577 · 2020: $2,913 · 2021: $5,506 · 2022: $2,659 · 2023: $3,811 · 2024: $1,191 · 2025: $4,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,890 · Travel and Lodging: $2,956 · Gift: $23.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,889.74 |
| Travel and Lodging | $2,955.95 |
| Gift | $23.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $13,598.90 | 2019-2025 | Triathlon, Blueprint Patient Specific Instrumentation, Reunion |
| Shoulder Innovations, INC. | $3,606.00 | 2025 | Inset System |
| Arthrex, INC. | $3,581.43 | 2019-2023 | |
| Smith+Nephew, INC. | $2,804.69 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium, Polarstem |
| Mvp Orthopedics INC | $1,725.24 | 2021-2023 | |
| Encore Medical, Lp | $1,055.17 | 2020-2021 | |
| Medical Device Business Services, INC. | $964.27 | 2019-2021 | |
| Coastal Medical Technologies LLC | $648.65 | 2023-2025 | |
| Depuy Synthes Sales INC. | $597.76 | 2019-2024 | Truespan Orthocord, Dynatape, Quickanchor Orthocord |
| Zimmer Biomet Holdings, INC. | $431.16 | 2022-2023 | Persona, Mymobility Platform |
| Linvatec Corporation | $311.68 | 2019-2020 | |
| Osteoremedies, LLC | $204.36 | 2024 | Remedy Spacer, Biobrush, Remedy Spectrum Gv Spacer |
| Pacira Pharmaceuticals Incorporated | $141.62 | 2019-2020 | |
| Vericel Corporation | $126.92 | 2024-2025 | Maci |
| Medtronic, INC. | $100.64 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $72.94 | 2021-2022 | |
| Organogenesis INC. | $72.55 | 2020 | |
| Anika Therapeutics, INC. | $71.44 | 2024 | Integrity |
| Arthrosurface Incorporated | $49.50 | 2020-2025 | Wristmotion Wrist Hemiarthroplasty System |
| Theragen, INC. | $48.85 | 2020-2023 | Kneehab Xp |
| Ferring Pharmaceuticals INC. | $46.00 | 2023-2024 | Euflexxa |
| Paragon 28, INC. | $39.00 | 2024 | Precision Mis Bunion |
| Ortho Development Corporation | $38.52 | 2021 | |
| Endo Pharmaceuticals INC. | $35.08 | 2023 | Xiaflex |
| Heraeus Medical, LLC. | $27.85 | 2020 | |
| Fidia Pharma USA INC. | $27.69 | 2020-2021 | |
| Orthofix Medical, INC. | $27.01 | 2025 | Physio-Stim |
| Pacira Therapeutics, INC. | $20.89 | 2019 | |
| Amgen INC. | $19.26 | 2021 | |
| Bioventus LLC | $12.60 | 2022 | |
| My01 INC. | $8.95 | 2022 | |
| Dynasplint Systems INC. | $8.40 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Vizzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.